ToxicR 22.01 (1.0.0)
Initial Release of ToxicR 1/28/2022.
Executable files are for R 4.1.2 in Windows/Mac(Intel/M1).
- The macOS release is single threaded due to OpenMP issues.
- The Windows release is multi-threaded
- For Linux compiles GSL (2.6 or greater) and NLOPT (2.4 or greater) libraries need to be installed.
Release Notes:
Dichotomous and Continuous Dose-Response functionality
Dichotomous
- MLE functionality (Equivalent to EPA BMDS 3.x)
- Bayesian MAP/Laplace (Equivalent to EPA BMDS 3.2+)
- Bayesian MCMC estimates
- Bayesian Model Averaging (MAP Equivalent to EPA BMDS 3.2+)
Continuous
- MLE functionality (Equivalent to EPA BMDS 3.x)
- Bayesian MAP/Laplace
- Bayesian MCMC estimates
- Bayesian Model Averaging
NTP Bioassay Tests
- Dose Dependent Trend Tests (e.g. Williams etc)
- PolyK Test
Methodologies Described in
Bailer, A.J. and Portier, C.J., 1988. Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small
samples. Biometrics, pp.417-431.
Wheeler, M.W., Blessinger, T., Shao, K., Allen, B.C., Olszyk, L., Davis, J.A. and Gift, J.S., 2020. Quantitative Risk Assessment:
Developing a Bayesian Approach to Dichotomous Dose–Response Uncertainty. Risk Analysis, 40(9), pp.1706-1722.
Wheeler, M.W. Cortinas,J. Aerts, M. Gift, J.S. Davis J.A., 2022. Continuous Model Averaging for Benchmark Dose Analysis: Averaging Over
Distributional Forms. Resubmitted to Environmetrics.